CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 1,868 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Molecular Therapy - Methods and Clinical Development
United States · Cell Press
workspace_premium Q1 — Molecular Biology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Molecular Therapy - Methods and Clinical Development

Molecular Therapy - Methods and Clinical Development is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 68. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2880 €. The scope of the journal is focused on technology development, molecular therapy, gene therapy. It has an SJR impact factor of 1,868 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,868.

Publisher: Cell Press
Category: Molecular Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,868 Q1
H-index 68
Acceptance rate pie_chart
32%
Source Acceptance_Rate
Time to publication hourglass_top
12 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
2.880 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

1,868

H-index

68

Docs (year)

200

Docs 3y

570

Total refs

9676

Cites 3y

2724

Citable 3y

528

Cites/Doc 2y

4.23

Ref/Doc

48.38

Immediate OA

2880 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Molecular Therapy - Methods and Clinical Development?

Molecular Therapy - Methods and Clinical Development has an SJR of 1,868 (best quartile Q1) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 2880 EUR.

What is the acceptance rate?

The acceptance rate recorded for Molecular Therapy - Methods and Clinical Development is 32%.